Board Member
Opus Genetics, Inc. (IRD)Equibles does not estimate personal net worth.
Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IRD alertsDr. Benjamin R. Yerxa is recorded as Board Member at Opus Genetics, Inc. (IRD). The newest filing on record that lists Dr. Benjamin R. Yerxa as Board Member at Opus Genetics, Inc. (IRD) is dated March 23, 2026. Opus Genetics, Inc. reported in an 8-K filed October 22, 2024 that Dr. Benjamin R. Yerxa was appointed President, effective October 22, 2024. Opus Genetics, Inc. reported in an 8-K filed October 22, 2024 that Dr. Benjamin R. Yerxa was appointed members of the Board, effective October 22, 2024. Dr. Benjamin R. Yerxa has spoken on 1 investor event across 1 company, most recently for Opus Genetics, Inc. on May 19, 2026. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.
“Dr. Yerxa, age 58, has also been appointed to serve as Ocuphire's President, effective October 22, 2024.”
“On October 22, 2024, effective immediately after the First Effective Time, Dr. Benjamin R. Yerxa, Ph.D., Dr. Jean Bennett, Ph.D., M.D., and Dr. Adrienne Graves, Ph.D., were appointed as members of the Board (such appointments, collectively the "Director Appointees").”
“We're co-founded by Dr. Jean Bennett, who you may know from, you know, she co-founded Spark, inventor of Luxterna. And we've been able to put seven assets into our portfolio.”
Proxy statement
Start not stated–present
Last confirmed March 23, 2026
Start not stated–present
Last confirmed March 23, 2026
Biotechnology · Healthcare
Board Member
